196 completed. 196 Phase 2, 28 Phase 1, 28 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 196 | Completed 196 |
| Phase 1 | 28 | Completed 28 |
| Phase 3 | 28 | Completed 28 |
Follow Embolism and Thrombosis: new trials by email Literature Review of Embolism and Thrombosis trials Research Report on Embolism and Thrombosis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study of the SCD411 Prefilled Syringe for Treating Adults With Wet Age-Related Macular Degeneration, Retinal Vein Occlusion, Diabetic Macular Edema, or Diabetic Retinopathy SCD411 0.05mL (2mg) - Neovascular (Wet) Age-Related Macular Degeneration, Retinal Vein Occlusion | Phase 2 | Completed | Sam Chun Dang Pharm. Co. Ltd. | 33 | 2026-05-13 | 2026-06-08 |
| A 2-part Study Consisting of a Multiple Ascending Dose Safety Study in Participants With Macular Edema Following Branch Retinal Vein Occlusion and a Dose-finding Safety and Preliminary Efficacy Study in Participants With Either Diabetic Macular Edema or Neovascular Age-related Macular Degeneration EYE201 - Diabetic Macular Edema (DME), Neovascular Age-related Macular Degeneration (NVAMD) | Phase 1 / Phase 2 | Completed | EyeBiotech Ltd. | 38 | 2024-11-12 | 2026-08-24 |
| A Trial to Learn How Well REGN9933 and REGN7508 Work for Preventing Blood Clots, and How Safe They Are, in Adults Who Have a Peripherally Inserted Central Catheter (PICC) REGN9933, REGN7508, Placebo - Venous Thromboembolism | Phase 2 | Completed | Regeneron Pharmaceuticals | 195 | 2024-09-20 | 2026-04-13 |
| A Trial to Learn How Well REGN7508 Works for Preventing Blood Clots After a Knee Replacement in Adult Participants REGN7508, Enoxaparin - Venous Thromboembolism | Phase 2 | Completed | Regeneron Pharmaceuticals | 179 | 2024-06-27 | 2026-05-27 |
| Tirofiban for Reduction of Thromboembolic Events in Endovascular Unruptured Aneurysm Repair Tirofiban, aspirin, clopidogrel - Unruptured Intracranial Aneurysm, Flow Diverter | Phase 2 / Phase 3 | Completed | Beijing Tiantan Hospital | 192 | 2024-03-04 | 2025-12-11 |
| A Study to Evaluate the Usability of the SB11 PFS in Subjects With Wet AMD or Macular Oedema Secondary to RVO SB11 PFS - Neovascular Age-related Macular Degeneration, Macular Edema | Phase 2 | Completed | Samsung Bioepis Co., Ltd. | 34 | 2023-11-21 | 2024-12-30 |
| Low Molecular Weight Heparin or no Treatment Following Cesarean Delivery Enoxaparin - Thromboembolism | Phase 2 | Completed | University of Utah | 64 | 2023-10-11 | 2025-09-04 |
| A Trial to Learn How Well REGN9933 Works for Preventing Blood Clots After Knee Replacement Surgery in Adult Participants REGN9933, Enoxaparin, Apixiban - Venous Thromboembolism | Phase 2 | Completed | Regeneron Pharmaceuticals | 373 | 2023-05-24 | 2025-08-29 |
| Safety and Proof of Concept Study of ANXV (Annexin A5) in Patients With Retinal Vein Occlusion ANXV - Retinal Vein Occlusion | Phase 2 | Completed | Annexin Pharmaceuticals AB | 16 | 2022-08-24 | 2024-12-11 |
| A Study to Evaluate BMS-986141 Added on to Aspirin or Ticagrelor or the Combination, on Thrombus Formation in a Thrombosis Chamber Model in Participants With Stable Coronary Artery Disease and Healthy Participants Ticagrelor, BMS-986141, Aspirin - Coronary Artery Disease, Healthy Participants | Phase 2 | Completed | Bristol-Myers Squibb | 58 | 2022-03-25 | 2023-12-05 |
| Enriched Heparin Anti COVID-19 Trial Heparin sodium, Placebo - Covid19 | Phase 1 / Phase 2 | Completed | UPECLIN HC FM Botucatu Unesp | 27 | 2021-06-01 | 2024-10-15 |
| A Study Evaluating the Safety and Preliminary Efficacy of sFilm-FS in Controlling Parenchymal Bleeding During Elective Hepatic Surgery sFilm-FS, TACHOSIL® - Hemostasis, General Surgery | Phase 1 / Phase 2 | Completed | Sealantium Medical Ltd. | 33 | 2021-05-12 | 2025-03-21 |
| Causes and Prevention of Thromboembolic Disease in Nephrotic Syndrome Dalteparin, Apixaban - Nephrotic Syndrome, Thromboembolic Disease | Phase 1 / Phase 2 | Completed | University of Aarhus | 57 | 2021-03-25 | 2025-04-11 |
| Assessing Feasibility of Thromboprophylaxis With Apixaban in JAK2-positive Myeloproliferative Neoplasm Patients Apixaban 2.5 MG Oral Tablet [ELIQUIS], Aspirin 81 mg - Myeloproliferative Neoplasm (MPN), Essential Thrombocythemia (ET) | Phase 2 | Completed | Ottawa Hospital Research Institute | 44 | 2021-02-17 | 2024-05-29 |
| 601 Versus Ranibizumab in Patients With Branch Retinal Vein Occlusion (BRVO) 601 1.25mg, Ranibizuman 0.5 mg - Branch Retinal Vein Occlusion | Phase 2 | Completed | Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. | 60 | 2021-01-28 | 2025-06-27 |
| 601 Versus Ranibizumab in Patients With Central Retinal Vein Occlusion (CRVO) 601 1.25mg, Ranibizuman 0.5 mg - Central Retinal Vein Occlusion | Phase 2 | Completed | Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. | 60 | 2021-01-27 | 2025-06-27 |
| Rivaroxaban Plus Aspirin to Manage Recurrent Venous Thromboembolic Events Rivaroxaban 20 MG [Xarelto], Aspirin 300mg, Acenocoumarol Oral Tablet - Venous Thromboembolism, Anticoagulant-induced Bleeding | Phase 2 / Phase 3 | Completed | Instituto Mexicano del Seguro Social | 58 | 2021-01-03 | 2022-08-25 |
| Assessing Safety, Hospitalization and Efficacy of rNAPc2 in COVID-19 rNAPc2, Heparin - Covid19 | Phase 2 / Phase 3 | Completed | ARCA Biopharma, Inc. | 160 | 2020-12-10 | 2023-02-21 |
| Fixed Dose Flavonoid Isoquercetin on Thrombo-Inflammatory Biomarkers in Subjects With Stable Sickle Cell Disease Isoquercetin, Placebo - Sickle Cell Disease | Phase 2 | Completed | National Heart, Lung, and Blood Institute (NHLBI) | 46 | 2020-11-02 | 2024-01-02 |
| Apixaban vs Enoxaparin Following Microsurgical Breast Reconstruction-An RCT Apixaban 2.5 MG Oral Tablet, Enoxaparin 40Mg/0.4mL Prefilled Syringe - Venous Thromboembolism | Phase 1 / Phase 2 | Completed | Stanford University | 82 | 2020-08-12 | 2025-06-22 |
Showing 20 of 196. Sign in to see all of them.
Venous Thromboembolism (53) · Thrombosis (52) · Venous Thrombosis (40) · Retinal Vein Occlusion (33) · Pulmonary Embolism (23) · Thromboembolism (23) · Macular Edema (16) · Raynaud Disease (16) · Hemorrhage (9) · Stroke (9) · Atrial Fibrillation (8) · Scleroderma, Systemic (7) · Ischemic Stroke (6) · COVID-19 (5)
Vascular Diseases (195) · Cardiovascular Diseases (193) · Thrombosis (86) · Thromboembolism (51) · Pathological Conditions, Signs and Symptoms (35) · Venous Thrombosis (34) · Eye Diseases (31) · Retinal Diseases (31) · Pathologic Processes (30) · Lung Diseases (27) · Respiratory Tract Diseases (27) · Embolism (21) · Retinal Degeneration (18) · Livedoid Vasculopathy (16)
Enoxaparin (34) · Rivaroxaban (18) · Warfarin (15) · apixaban (14) · Ranibizumab (11) · Aspirin (10) · Heparin (8) · Dalteparin (7) · Dabigatran (6) · edoxaban (6) · Clopidogrel (5) · Dexamethasone (4) · Fondaparinux (4) · Bevacizumab (3) · Tablets (3)
Bayer (12) · Astellas Pharma Inc (7) · Boehringer Ingelheim (7) · Bristol-Myers Squibb (6) · Daiichi Sankyo (5) · Ottawa Hospital Research Institute (5) · University of Utah (5) · ARCA Biopharma, Inc. (4) · Hamilton Health Sciences Corporation (3) · MediQuest Therapeutics (3) · Pfizer (3) · Regeneron Pharmaceuticals (3) · Sanofi (3) · Agen Biomedical (2) · Allergan (2)
United States (102) · Canada (42) · Germany (22) · Italy (22) · Poland (21) · Austria (19) · Israel (19) · France (18) · Spain (17) · Russia (16) · United Kingdom (16) · Australia (15) · Denmark (14) · Netherlands (14) · Japan (13)
Christopher Puccini, MD (3) · Peter A Campochiaro, MD (3) · Catherine A Cukras, M.D. (2) · Sam Schulman, MD, PhD (2) · Aaron Gillam (1) · Abhijit Munshi (1)
PMID 33086312, PMID 33337539, PMID 38189593, PMID 31420317, PMID 33502773, PMID 33779986, PMID 34622445, PMID 35244208, PMID 41218619, PMID 15893169, PMID 16458642, PMID 16531440, PMID 17353400, PMID 17599602, PMID 18082503, PMID 18088349, PMID 18178417, PMID 18195173, PMID 18307999, PMID 18360849, PMID 18402906, PMID 18621928, PMID 19187076, PMID 19268890, PMID 19365011, PMID 19640572, PMID 19737719, PMID 19854398, PMID 20212194, PMID 20212197, PMID 20442358, PMID 20448094, PMID 20886185, PMID 21106014, PMID 21600028, PMID 21621252, PMID 21664144, PMID 21680946, PMID 21794899, PMID 21932952, PMID 22084331, PMID 22100906, PMID 22284935, PMID 22431865, PMID 22503057, PMID 22683421, PMID 22960949, PMID 23273695, PMID 23394476, PMID 23680957
2014 (3), 2016 (3), 2005 (2), 2008 (2), 2018 (2), 2023 (2), 1UG1EY026876-01A1 (1), 1UG1EY028517-01 (1), 1UM1HL113203-01A1 (1), 2004 (1), 2009 (1), 2015 (1), 2019 (1), P50NS044283 (1), R42HL086316 (1)